Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cynata Therapeutics Limited (AU:CYP)
ASX:CYP
Cynata Therapeutics Limited (CYP) Share Price & Analysis
1 Followers
CYP Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.11 - AU$0.36
Previous CloseAU$0.12
Volume50.00K
Average Volume (3M)53.36K
Market Cap
AU$22.45M
Enterprise Value-AU$1.34M
Total Cash (Recent Filing)AU$23.80M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)-1.2
Beta0.52
Next Earnings
Feb 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding179,631,786
10 Day Avg. Volume194,861
30 Day Avg. Volume53,356
Standard Deviation0.18
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
3.72% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
96.28% Public Companies and
Individual Investors
CYP FAQ
What was Cynata Therapeutics Limited’s price range in the past 12 months?
Cynata Therapeutics Limited lowest share price was AU$0.10 and its highest was AU$0.36 in the past 12 months.
What is Cynata Therapeutics Limited’s market cap?
Currently, no data Available
When is Cynata Therapeutics Limited’s upcoming earnings report date?
Cynata Therapeutics Limited’s upcoming earnings report date is Feb 27, 2024 which is in 80 days.
How were Cynata Therapeutics Limited’s earnings last quarter?
Cynata Therapeutics Limited released its earnings results on Aug 28, 2023. The company reported -AU$0.062 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.062.
Is Cynata Therapeutics Limited overvalued?
According to Wall Street analysts Cynata Therapeutics Limited’s price is currently Overvalued.
Does Cynata Therapeutics Limited pay dividends?
Cynata Therapeutics Limited does not currently pay dividends.
What is Cynata Therapeutics Limited’s EPS estimate?
Cynata Therapeutics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cynata Therapeutics Limited have?
Cynata Therapeutics Limited has 179,631,790 shares outstanding.
What happened to Cynata Therapeutics Limited’s price movement after its last earnings report?
Cynata Therapeutics Limited reported an EPS of -AU$0.062 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.571%.
Which hedge fund is a major shareholder of Cynata Therapeutics Limited?
Currently, no hedge funds are holding shares in AU:CYP
---
Cynata Therapeutics Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:CYP Sentiment 77%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $8.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.00%
12-Months-Change
Fundamentals
Return on Equity
-69.64%
Trailing 12-Months
Asset Growth
-30.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cynata Therapeutics Limited
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which has branded Cymerus.
---
Athersys
―
Mesoblast
―
Cyclerion Therapeutics
―
BioLife Solutions
―
Cynata Therapeutics Limited
―
---